- Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Current treatment options for renal cell carcinoma and outlook2020 | Publication without faculty affiliation
- Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'2020 | Publication without faculty affiliation